Reply to “Embracing imatinib: a novel approach to safeguarding the endothelial barrier in patients with COVID-19”
Crossref DOI link: https://doi.org/10.1007/s10456-023-09894-5
Published Online: 2023-09-02
Published Print: 2023-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wu, Xiaoming
Shi, Jialan http://orcid.org/0000-0001-5642-5436
Text and Data Mining valid from 2023-09-02
Version of Record valid from 2023-09-02
Article History
Received: 3 August 2023
Accepted: 8 August 2023
First Online: 2 September 2023
Declarations
:
: The authors declare no competing interests.